Prescription Drug Provisions in the Inflation Reduction Act: Any Relief of Financial Hardship for Patients With Cancer?

JAMA Oncol. 2023 Feb 1;9(2):165-167. doi: 10.1001/jamaoncol.2022.5805.

Authors

Ya-Chen Tina Shih¹, K Robin Yabroff², Cathy J Bradley³

Affiliations

¹ Section of Cancer Economics and Policy, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston.
² Surveillance and Health Equity Science Department, American Cancer Society, Atlanta, Georgia.
³ University of Colorado Comprehensive Cancer Center and Colorado School of Public Health, Aurora.

No abstract available

Plain language summary

This Viewpoint discusses the potential of provisions of the Inflation Reduction Act of 2022 to mitigate cancer-related financial hardship.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Cancer Survivors*
Financial Stress
Health Expenditures
Humans
Neoplasms* / drug therapy
Prescription Drugs*

Substances

Prescription Drugs

Grants and funding